Table 8.6g

Immunosuppression Use for Maintenance Between Discharge

		Year of Transplant
		1998	1999	2000	2001	2002	2003	2004	2005	2006	2007
Transplants		972	941	915	891	905	871	881	903	924	862
Tx with Follow-up Immunosuppression Info		870	859	840	818	821	785	791	824	819	766
Corticosteroids	Any in Category	99.7%	99.5%	95.6%	93.4%	89.4%	81.9%	75.9%	73.5%	71.6%	71.4%
Corticosteroids	Steroids	99.7%	99.5%	95.6%	93.4%	89.4%	81.9%	75.9%	73.5%	71.6%	71.4%
Cyclosporine	Any in Category	36.3%	31.1%	23.0%	17.0%	13.4%	11.8%	8.6%	7.3%	7.0%	7.8%
	Cyclosporin	0.0%	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%
	Sandimmmune	4.1%	5.0%	3.1%	1.8%	1.3%	0.6%	0.5%	0.1%	0.1%	0.4%
	Neoral	32.2%	25.8%	18.7%	12.3%	8.8%	9.2%	6.7%	5.5%	5.5%	6.9%
	Gengraf	0.0%	0.2%	1.2%	2.7%	3.2%	2.0%	1.4%	1.7%	1.3%	0.5%
	Eon	0.0%	0.0%	0.0%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Tacrolimus	Any in Category	75.2%	80.7%	84.3%	89.2%	89.9%	87.6%	87.7%	93.3%	92.2%	93.9%
Tacrolimus	Tacrolimus	75.2%	80.7%	84.3%	89.2%	89.9%	87.6%	87.7%	93.3%	92.2%	93.9%
Antimetabolites	Any in Category	96.8%	95.7%	87.5%	80.4%	82.2%	82.5%	86.6%	86.3%	87.9%	89.7%
	Mycophenolate Mofetil	84.9%	87.4%	81.2%	77.5%	79.8%	80.3%	80.2%	75.0%	69.8%	69.6%
	Mycophenolate Sodium	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	4.7%	10.2%	16.0%	18.3%
	Azathioprine	11.8%	8.3%	6.3%	2.9%	2.4%	2.2%	1.6%	0.8%	1.2%	1.3%
	Leflunomide	0.0%	0.0%	0.0%	0.0%	0.0%	0.1%	0.1%	0.2%	0.9%	0.5%
	Cytoxan	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
mTOR Inhibitors	Any in Category	2.0%	5.2%	21.0%	31.2%	27.8%	27.5%	24.0%	22.1%	19.2%	15.0%
	Sirolimus	0.9%	4.8%	20.5%	31.1%	27.8%	27.5%	24.0%	22.1%	19.2%	15.0%
	Everolimus	1.0%	0.5%	0.5%	0.1%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%